News
Calm deal causes Ripple effect in the boardroom
This month’s acquisition of health tech firm Ripple by relaxation app Calm has seen Ripple’s CEO David Ko appointed Calm’s co-CEO.
Ko will share the CEO berth with Michael Acton Smith, co-founder of Calm.
Ripple is focused on finding “the most impactful ways to bring physical, mental, and social help to every person”.
It recently introduced its first two products Care Memo and LikePaper.
They are aimed at identifying and closing gaps in care while reducing the burden of caregiving.
They “offer caregivers peace of mind through simple and innovative technology solutions” that help them check on, monitor and manage a loved one’s health.
Calm and Ripple will focus on expanding their mental health offers, Tech Times reports, bringing more services and assistance for people who use it.
UK Biobank releases world’s largest single set of sequencing data
Listen: Longevity, Eastern wisdom and Western science
Fundamental principles of healthcare digital twins
Tackling the diagnostic testing sustainability problem
Gym-going men ‘unaware’ of protein risk to fertility
Anti-choke mug protects Parkinson’s patients
AI model predicts breast cancer risk without racial bias
TheHill secures UK gov funding and Barclays support to help advance digital innovation
Real time data collection changes the game for the stroke patient pathway
Inside BT’s mission to boost NHS connectivity
Products4 weeks agoPioneering paediatric pressure ulcer mattress to be showcased at MEDICA 2023
- Diagnostics3 weeks ago
3D model will advance understanding of spinal injury pathology
- Opinion4 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- Biotech4 weeks ago
LiliumX unveils rebrand as Valink Therapeutics and appointment of new board and execs after securing $7.8m investment
